| 查看: 267 | 回复: 11 | |||
[交流]
【深容SCI写作智能体】Abstract实测
|
|||
|
【深容SCI写作智能体】Abstract实测 如需试用【深容SCI写作智能体】，请联系深容张老师：shenrongagent [https://scioriginal.com] 上月深容推出了【深容SCI写作智能体】的Method，Introduction，Discussion智能体，写作质量非常高，全部真实参考文献，深受用户欢迎。 今天介绍的Abstract写作智能体，功能相对简单，根据用户提供的正文内容，快速起草摘要，同时输出结构式摘要和一体式摘要。 1. 用户输入正文内容： 2. 检索参考同类题材的摘要格式： 3. 输出结果Abstract。 智能体的写作质量非常高： (1) Structured ABSTRACT 1) Background Signal Transducer and Activator of Transcription 2 (STAT2) is well-known for its role in type I interferon (IFN-I) signaling, which is generally considered tumor-suppressive. However, its direct role in cancer, particularly colorectal cancer (CRC), remains underexplored. Given the critical involvement of immune and cytokine networks in CRC progression, elucidating STAT2's contribution is essential. 2) Methods We analyzed TCGA-COAD datasets to assess STAT2 and IFNAR1 expression and patient survival. Human HCT116 and murine MC38 cell lines with STAT2 or IFNAR1 knockouts were generated using CRISPR\/Cas9 technology. Cell proliferation was measured in vitro using the CellTiter 96 assay. In vivo tumor growth was evaluated by subcutaneous injection of knockout and control cells into immunodeficient or immunocompetent mice. Western blot and qPCR analyses were performed to assess downstream signaling and gene expression changes. 3) Results High STAT2 expression in TCGA-COAD tumors correlated with reduced patient survival, independent of IFNAR1 levels. STAT2 deletion impaired cell proliferation and tumor growth in both human and murine models, whereas IFNAR1 deletion did not. STAT2 KO cells exhibited reduced STAT1 activation but enhanced STAT3 phosphorylation, indicating distinct downstream signaling effects compared to IFNAR1 KO cells. These findings suggest that STAT2 promotes tumorigenicity through mechanisms distinct from canonical IFN-I signaling. 4) Conclusion Our study reveals that STAT2 functions as a tumor-promoting factor in CRC, acting independently of IFNAR1-mediated IFN-I signaling. Targeting STAT2 or its downstream pathways may offer a novel therapeutic strategy for mitigating CRC progression. --- (2) Integrated ABSTRACT Signal Transducer and Activator of Transcription 2 (STAT2) is a key mediator of type I interferon (IFN-I) signaling, traditionally viewed as tumor-suppressive. However, its direct role in colorectal cancer (CRC) remains poorly defined, despite the critical influence of immune and cytokine networks on disease progression. To address this gap, we analyzed TCGA-COAD datasets and found that high STAT2 expression in CRC tumors correlated with reduced patient survival, independent of IFNAR1 levels. Using CRISPR\/Cas9 technology, we generated human HCT116 and murine MC38 cell lines with STAT2 or IFNAR1 knockouts. In vitro cell proliferation assays demonstrated that STAT2 deletion significantly impaired growth, whereas IFNAR1 deletion had no effect. In vivo studies in immunodeficient and immunocompetent mice confirmed that STAT2 KO cells formed smaller tumors compared to controls, while IFNAR1 KO cells did not differ significantly from wild-type cells. Western blot and qPCR analyses revealed that STAT2 deletion reduced STAT1 activation but enhanced STAT3 phosphorylation, indicating distinct downstream signaling effects compared to IFNAR1 KO cells. These findings suggest that STAT2 promotes tumorigenicity through mechanisms independent of canonical IFN-I signaling. Our study highlights STAT2 as a potential therapeutic target in CRC, offering new avenues for mitigating disease progression by targeting its pro-tumorigenic pathways. 以上这篇Abstract起草时间仅00:01:35 【深容SCI写作智能体】包括四大模块：Method智能体、Introduction智能体、Discussion智能体、Abstract智能体。 如需试用智能体，请徽售联系深容张老师：shenrongagent [https://scioriginal.com] #SCI论文 #科研 #实验 #博士 #投稿     |
回复此楼» 猜你喜欢
招调剂
已经有10人回复
-
欢迎211本科同学，过A区国家线，A区非偏远一本，交叉学科课题组
已经有23人回复
-
A区一本交叉课题组，低分调剂，招收机械电子信息通信等交叉方向
已经有31人回复
-
中科大材料299求调剂
已经有7人回复
-
301求调剂
已经有3人回复
-
材料与化工304求调剂
已经有9人回复
-
材料考研339求调剂
已经有3人回复
-
材料专硕290求调剂
已经有5人回复
-
080500材料科学与工程
已经有13人回复
-
304求调剂
已经有4人回复
» 抢金币啦！回帖就可以得到:
-
江西师范大学陶端健教授团队2026年硕士研究生招生公告
+1/231
-
江西科技师范大学微生物天然药物老师介绍
+1/86
-
化学、材料科学与工程、高分子及复合材料方向研究生招生
+1/84
-
东北石油大学三亚海洋油气研究院【硕士招生】【地质资源与地质工程】【地质学】
+1/76
-
香港科技大学（广州）科研助理（生物医药领域）招聘启事
+1/54
-
西安工程大学能源化工新材料研发项目组接收2026年研究生
+1/35
-
2026年北京石油化工学院环境学科-水污染控制工程方向课题组欢迎您
+1/20
-
现在科研环境这么差，我想这样试试
+1/19
-
华南理工大学自旋科技研究院谢弘超课题组招收2026秋季博士、硕士研究生
+1/18
-
青岛科技大学-材料学院-青年泰山学者团队招收多名硕士及调剂生-欢迎咨询！
+1/9
-
韩国双院院士、JACS 副主编 Kisuk Kang 教授招聘博士后/研究员（钠离子电池）
+1/7
-
北京航空航天大学26级博士招生-生物医学工程-合成生物学
+1/6
-
中科院深圳先进技术研究院成会明院士/唐永炳杰青团队拟招聘博士后若干名。
+1/5
-
0858电气专硕364求调剂
+1/5
-
南京工业大学-陆小华教授课题组招收博士研究生-分子与界面化学工程
+1/4
-
#南方科技大学# 仿生医药与材料实验室 招高分子方向博士生、科研助理
+1/3
-
北京化工大学Ulrich Schwaneberg/季宇教授课题组2026年招收博士生
+1/3
-
【全奖, 免GRE】美国科罗拉多大学科罗拉多斯普林斯分校----固体力学
+1/2
-
清华大学深圳国际研究生院张旻课题组招收2027级博士生_机械、仪器方向
+1/1
-
中国科学院大学杭州高等研究院 胶体量子点材料与器件方向 博士后招聘
+1/1
简单回复
夏末末872楼
2026-01-11 18:20
回复
pheiphei2025(金币+1): 谢谢参与
1 发自小木虫手机客户端
2026-01-11 18:31
回复
jiaoxg4楼
2026-01-11 18:39
回复
pheiphei2025(金币+1): 谢谢参与
tfang5楼
2026-01-11 18:42
回复
pheiphei2025(金币+1): 谢谢参与
2026-01-11 18:51
回复
pheiphei2025(金币+1): 谢谢参与
2026-01-11 19:04
回复
toppaper8楼
2026-01-11 20:07
回复
XG-WUST9楼
2026-01-11 21:35
回复
pheiphei2025(金币+1): 谢谢参与
up 发自小木虫IOS客户端
psylhh10楼
2026-01-11 22:21
回复
pheiphei2025(金币+1): 谢谢参与
庚辰辛丑11楼
2026-01-12 07:28
回复
pheiphei2025(金币+1): 谢谢参与
afit88812楼
2026-01-12 11:17
回复
